Matthew K. Ito
Matthew K. Ito publishes mostly in Surgery, Economics and Econometrics and Endocrinology, Diabetes and Metabolism, on topics such as Lipoproteins and Cardiovascular Health, Diabetes, Cardiovascular Risks, and Lipoproteins and Pharmaceutical Economics and Policy.
- World rank
- #1,576,047 of 7,710,434 ranked researchers
- Rank in United States
- #491,162 of 1,627,098
- Works
- 93
- Citations
- 6.2k
- Citations per work
- 66.3
What does Matthew K. Ito research?
Matthew K. Ito's work is mostly in Medicine (44%), Economics, Econometrics and Finance (10%), Biochemistry, Genetics and Molecular Biology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences4143.9%
- Medicine4143.9%
- Everything else3739.7%
- Social Sciences1010.4%
- Life Sciences66.0%
- 1Surgery23% of their works
- 2Economics and Econometrics10% of their works
- 3Endocrinology, Diabetes and Metabolism9% of their works
- 4Cardiology and Cardiovascular Medicine6% of their works
- 5Cancer Research6% of their works
- 6Geriatrics and Gerontology6% of their works
Research topics
- Lipoproteins and Cardiovascular Health
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Pharmaceutical Economics and Policy
- Pharmaceutical Practices and Patient Outcomes
- Cancer, Lipids, and Metabolism
- Health Systems, Economic Evaluations, Quality of Life
- Lipid metabolism and disorders
- Pharmaceutical studies and practices
Which keywords describe Matthew K. Ito's research?
The keywords of their largest research topics: Statins, Clinical Trials, Cardiovascular Disease Prevention, Cholesterol-lowering, Cholesterol, Atherosclerosis, Metabolic Syndrome and Cardiovascular Disease.
- Off-Label Drug Use
- ANGPTL3
- Cost-effectiveness Analysis
- Fatty Acid Synthase
- Inappropriate Medication Use
- Drug Development Costs
- Cardiovascular Disease
- Atherosclerosis
- Cholesterol-lowering
- Clinical Trials
- Statins
- Cardiovascular Disease Prevention
- Cholesterol
- Metabolic Syndrome
- Diabetes
- Generic Drugs
- Polypharmacy
- Lipid Metabolism
- Quality of Life
- Lipoprotein Lipase
- Pediatric Pharmacokinetics
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 21 words, with their numbers
- Statins672 topics
- Clinical Trials612 topics
- Cardiovascular Disease Prevention551 topic
- Cholesterol-lowering551 topic
- Cholesterol322 topics
- Atherosclerosis272 topics
- Metabolic Syndrome272 topics
- Cardiovascular Disease201 topic
- Diabetes201 topic
- Drug Development Costs151 topic
- Generic Drugs151 topic
- Inappropriate Medication Use141 topic
- Polypharmacy141 topic
- Fatty Acid Synthase121 topic
- Lipid Metabolism121 topic
- Cost-effectiveness Analysis101 topic
- Quality of Life101 topic
- ANGPTL371 topic
- Lipoprotein Lipase71 topic
- Off-Label Drug Use61 topic
- Pediatric Pharmacokinetics61 topic
Where does Matthew K. Ito work?
Matthew K. Ito's main affiliation in the publication record is Oregon Health & Science University, United States.
How many publications and citations does Matthew K. Ito have?
OpenAlex counts 93 works and 6,170 citations for Matthew K. Ito, an h-index of 28, ranking #1,576,047 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Matthew K. Ito. Posts are plain text and can be reported.